Call us on +33 1 4151 5490



Checked by OPHTAZON

Possible installation on quotation

OPTOVUE iVue 100-2 – Spectral-Domain OCT in perfect condition
Optovue

Buy now 10 000 €

ref : 13904
Available on 2026-12-28
Latest check up : 2026

Possible installation on quotation

Description

Used equipment selected by OPHTAZON

Cosmetic condition: well-maintained appearance
Functional condition: main features tested and verified.
Complete set: includes computer (PC) and electric table.
Included modules and options: corneal module, ganglion cell analysis (GCC), and 3D imaging.
Performance: reliability and accuracy of anterior and posterior segment examinations.
Advantage: excellent value for money to equip your ophthalmology practice.

Express delivery available upon request.

Technical description

The OPTOVUE iVue 100-2 is a spectral-domain optical coherence tomography (SD-OCT) device designed for the examination and analysis of ocular structures.

It is used, in particular, for the diagnosis and monitoring of retinal, macular, and optic nerve conditions, especially in the context of glaucoma.
Technical Specifications
Specification Value
Spectral-domain OCT technology
Acquisition rate 26,000 A-scans/second
Axial resolution 5 µm
Transverse resolution 15 µm
Wavelength 840 ± 10 nm
Depth of analysis 2 to 2.3 mm
Frontal OCT field of view 21° × 21°
Minimum pupil diameter 2.5 mm
Focusing Motorized
Weight with table Approximately 36 kg

These values correspond to the iVue 100 series; certain specifications may vary depending on the configuration of the 100-2.

Clinical Applications
- Retina: macular mapping, retinal thickness measurements, and OCT sections.
- Glaucoma: RNFL analysis, GCC, and optic nerve head analysis.
- Anterior segment: pachymetry, corneal analysis, and iridocorneal angle measurement, depending on the installed modules.
- Follow-up: comparison of successive examinations and progression analysis.

Similar products

Nous utilisons différentes technologies pour optimiser votre expérience utilisateur.
Merci de cliquer sur le bouton pour donner votre accord.

Vous souhaitez en savoir plus ? Cliquez ici

Annuler